Loading…

Cardiac Syndrome X: Advances in Treatment for Chest Pain without Artery Stenosis

The number of patients diagnosed with Cardiac Syndrome X continues to increase. This condition is marked by anginal pain despite the absence of abnormal findings on coronary angiography or coronary spasm. It is considered a form of ischemic heart disease, with its incidence being most common among w...

Full description

Saved in:
Bibliographic Details
Published in:Journal of education, health and sport health and sport, 2024-12, Vol.76, p.56434
Main Authors: Tulej, Dawid, Furtak, Daria, Dziedzic, Alicja, Niewiadomska, Jagoda, Marko, Natalia, Grela, Wiktor, Głogowska, Paulina, Marciniuk, Dominika, Górska, Aleksandra, Gniaź, Natalia
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue
container_start_page 56434
container_title Journal of education, health and sport
container_volume 76
creator Tulej, Dawid
Furtak, Daria
Dziedzic, Alicja
Niewiadomska, Jagoda
Marko, Natalia
Grela, Wiktor
Głogowska, Paulina
Marciniuk, Dominika
Górska, Aleksandra
Gniaź, Natalia
description The number of patients diagnosed with Cardiac Syndrome X continues to increase. This condition is marked by anginal pain despite the absence of abnormal findings on coronary angiography or coronary spasm. It is considered a form of ischemic heart disease, with its incidence being most common among women in the perimenopausal and postmenopausal stages. The aim of this article is to review therapeutic options for Cardiac Syndrome X. The most effective treatments commonly used include calcium channel blockers and beta-blockers, including newer generation options that promote vasodilation in the endothelium. Angiotensin-converting enzyme (ACE) inhibitors are also frequently used to enhance therapeutic outcomes. Other medications used were nitrates, statins, ranolazine, imipramine, nicorandil, aminophylline, cilostazol, sildenafil, fasudil. Emerging theories suggest altered pain perception, potentially involving heightened neural sensitivity, may significantly contribute to the symptoms in CSX. Additionally, studies indicate that vitamin D supplementation, often beneficial for cardiovascular health, may alleviate symptoms in CSX. Non-pharmacological methods also have proven efficacy, such as Enhanced External Counterpulsation, spinal cord stimulation and transcutaneous electrical nerve stimulation. Lifestyle changes and (CBT) also play a crucial role in the comprehensive management of Cardiac Syndrome X (CSX), targeting factors that pharmacological treatments alone may not address.
doi_str_mv 10.12775/JEHS.2024.76.56434
format article
fullrecord <record><control><sourceid>doaj_cross</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_040413007c4440888e8922302826e3e1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_040413007c4440888e8922302826e3e1</doaj_id><sourcerecordid>oai_doaj_org_article_040413007c4440888e8922302826e3e1</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1101-dad73975681c69e82201696e5b8e2d1401b5fdb5d92128de9bfc199c45786df13</originalsourceid><addsrcrecordid>eNpNkN1KAzEQhRdRsNQ-gTd5ga2Z_G3iXVmqrRQstIJ3IZvM2i3triSr0re3rSJezWEOfBy-LLsFOgZWFPLuaTpbjRllYlyosVSCi4tswLiBXHOqLv_l62yU0pZSCkoCSDrIlqWLoXGerA5tiN0eyes9mYRP13pMpGnJOqLr99j2pO4iKTeYerJ0x-Kr6TfdR08mscd4IKse2y416Sa7qt0u4ej3DrOXh-m6nOWL58d5OVnkHoBCHlwouCmk0uCVQc3YcZNRKCuNLICgUMk6VDIYBkwHNFXtwRgvZKFVqIEPs_kPN3Rua99js3fxYDvX2POji2_Wxb7xO7RUUAGc0sILIajWGrVhjFOmmUKOJxb_YfnYpRSx_uMBtWfH9uTYnhzbQtmzY_4NACtsog</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Cardiac Syndrome X: Advances in Treatment for Chest Pain without Artery Stenosis</title><source>DOAJ Directory of Open Access Journals</source><creator>Tulej, Dawid ; Furtak, Daria ; Dziedzic, Alicja ; Niewiadomska, Jagoda ; Marko, Natalia ; Grela, Wiktor ; Głogowska, Paulina ; Marciniuk, Dominika ; Górska, Aleksandra ; Gniaź, Natalia</creator><creatorcontrib>Tulej, Dawid ; Furtak, Daria ; Dziedzic, Alicja ; Niewiadomska, Jagoda ; Marko, Natalia ; Grela, Wiktor ; Głogowska, Paulina ; Marciniuk, Dominika ; Górska, Aleksandra ; Gniaź, Natalia</creatorcontrib><description>The number of patients diagnosed with Cardiac Syndrome X continues to increase. This condition is marked by anginal pain despite the absence of abnormal findings on coronary angiography or coronary spasm. It is considered a form of ischemic heart disease, with its incidence being most common among women in the perimenopausal and postmenopausal stages. The aim of this article is to review therapeutic options for Cardiac Syndrome X. The most effective treatments commonly used include calcium channel blockers and beta-blockers, including newer generation options that promote vasodilation in the endothelium. Angiotensin-converting enzyme (ACE) inhibitors are also frequently used to enhance therapeutic outcomes. Other medications used were nitrates, statins, ranolazine, imipramine, nicorandil, aminophylline, cilostazol, sildenafil, fasudil. Emerging theories suggest altered pain perception, potentially involving heightened neural sensitivity, may significantly contribute to the symptoms in CSX. Additionally, studies indicate that vitamin D supplementation, often beneficial for cardiovascular health, may alleviate symptoms in CSX. Non-pharmacological methods also have proven efficacy, such as Enhanced External Counterpulsation, spinal cord stimulation and transcutaneous electrical nerve stimulation. Lifestyle changes and (CBT) also play a crucial role in the comprehensive management of Cardiac Syndrome X (CSX), targeting factors that pharmacological treatments alone may not address.</description><identifier>ISSN: 2391-8306</identifier><identifier>EISSN: 2391-8306</identifier><identifier>DOI: 10.12775/JEHS.2024.76.56434</identifier><language>eng</language><publisher>Kazimierz Wielki University</publisher><subject>cardiac syndrome X ; ischemic heart disease ; microvascular angina ; pharmacological therapy</subject><ispartof>Journal of education, health and sport, 2024-12, Vol.76, p.56434</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0009-0003-2219-984X ; 0009-0008-3329-9770 ; 0000-0003-0768-9800 ; 0009-0000-0710-8485 ; 0009-0004-0141-2821 ; 0009-0002-3003-4466 ; 0000-0002-5711-3423 ; 0009-0004-7815-4592 ; 0009-0001-0460-4106 ; 0009-0000-5801-5756</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,864,2101,27923,27924</link.rule.ids></links><search><creatorcontrib>Tulej, Dawid</creatorcontrib><creatorcontrib>Furtak, Daria</creatorcontrib><creatorcontrib>Dziedzic, Alicja</creatorcontrib><creatorcontrib>Niewiadomska, Jagoda</creatorcontrib><creatorcontrib>Marko, Natalia</creatorcontrib><creatorcontrib>Grela, Wiktor</creatorcontrib><creatorcontrib>Głogowska, Paulina</creatorcontrib><creatorcontrib>Marciniuk, Dominika</creatorcontrib><creatorcontrib>Górska, Aleksandra</creatorcontrib><creatorcontrib>Gniaź, Natalia</creatorcontrib><title>Cardiac Syndrome X: Advances in Treatment for Chest Pain without Artery Stenosis</title><title>Journal of education, health and sport</title><description>The number of patients diagnosed with Cardiac Syndrome X continues to increase. This condition is marked by anginal pain despite the absence of abnormal findings on coronary angiography or coronary spasm. It is considered a form of ischemic heart disease, with its incidence being most common among women in the perimenopausal and postmenopausal stages. The aim of this article is to review therapeutic options for Cardiac Syndrome X. The most effective treatments commonly used include calcium channel blockers and beta-blockers, including newer generation options that promote vasodilation in the endothelium. Angiotensin-converting enzyme (ACE) inhibitors are also frequently used to enhance therapeutic outcomes. Other medications used were nitrates, statins, ranolazine, imipramine, nicorandil, aminophylline, cilostazol, sildenafil, fasudil. Emerging theories suggest altered pain perception, potentially involving heightened neural sensitivity, may significantly contribute to the symptoms in CSX. Additionally, studies indicate that vitamin D supplementation, often beneficial for cardiovascular health, may alleviate symptoms in CSX. Non-pharmacological methods also have proven efficacy, such as Enhanced External Counterpulsation, spinal cord stimulation and transcutaneous electrical nerve stimulation. Lifestyle changes and (CBT) also play a crucial role in the comprehensive management of Cardiac Syndrome X (CSX), targeting factors that pharmacological treatments alone may not address.</description><subject>cardiac syndrome X</subject><subject>ischemic heart disease</subject><subject>microvascular angina</subject><subject>pharmacological therapy</subject><issn>2391-8306</issn><issn>2391-8306</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpNkN1KAzEQhRdRsNQ-gTd5ga2Z_G3iXVmqrRQstIJ3IZvM2i3triSr0re3rSJezWEOfBy-LLsFOgZWFPLuaTpbjRllYlyosVSCi4tswLiBXHOqLv_l62yU0pZSCkoCSDrIlqWLoXGerA5tiN0eyes9mYRP13pMpGnJOqLr99j2pO4iKTeYerJ0x-Kr6TfdR08mscd4IKse2y416Sa7qt0u4ej3DrOXh-m6nOWL58d5OVnkHoBCHlwouCmk0uCVQc3YcZNRKCuNLICgUMk6VDIYBkwHNFXtwRgvZKFVqIEPs_kPN3Rua99js3fxYDvX2POji2_Wxb7xO7RUUAGc0sILIajWGrVhjFOmmUKOJxb_YfnYpRSx_uMBtWfH9uTYnhzbQtmzY_4NACtsog</recordid><startdate>20241221</startdate><enddate>20241221</enddate><creator>Tulej, Dawid</creator><creator>Furtak, Daria</creator><creator>Dziedzic, Alicja</creator><creator>Niewiadomska, Jagoda</creator><creator>Marko, Natalia</creator><creator>Grela, Wiktor</creator><creator>Głogowska, Paulina</creator><creator>Marciniuk, Dominika</creator><creator>Górska, Aleksandra</creator><creator>Gniaź, Natalia</creator><general>Kazimierz Wielki University</general><scope>AAYXX</scope><scope>CITATION</scope><scope>DOA</scope><orcidid>https://orcid.org/0009-0003-2219-984X</orcidid><orcidid>https://orcid.org/0009-0008-3329-9770</orcidid><orcidid>https://orcid.org/0000-0003-0768-9800</orcidid><orcidid>https://orcid.org/0009-0000-0710-8485</orcidid><orcidid>https://orcid.org/0009-0004-0141-2821</orcidid><orcidid>https://orcid.org/0009-0002-3003-4466</orcidid><orcidid>https://orcid.org/0000-0002-5711-3423</orcidid><orcidid>https://orcid.org/0009-0004-7815-4592</orcidid><orcidid>https://orcid.org/0009-0001-0460-4106</orcidid><orcidid>https://orcid.org/0009-0000-5801-5756</orcidid></search><sort><creationdate>20241221</creationdate><title>Cardiac Syndrome X: Advances in Treatment for Chest Pain without Artery Stenosis</title><author>Tulej, Dawid ; Furtak, Daria ; Dziedzic, Alicja ; Niewiadomska, Jagoda ; Marko, Natalia ; Grela, Wiktor ; Głogowska, Paulina ; Marciniuk, Dominika ; Górska, Aleksandra ; Gniaź, Natalia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1101-dad73975681c69e82201696e5b8e2d1401b5fdb5d92128de9bfc199c45786df13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>cardiac syndrome X</topic><topic>ischemic heart disease</topic><topic>microvascular angina</topic><topic>pharmacological therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tulej, Dawid</creatorcontrib><creatorcontrib>Furtak, Daria</creatorcontrib><creatorcontrib>Dziedzic, Alicja</creatorcontrib><creatorcontrib>Niewiadomska, Jagoda</creatorcontrib><creatorcontrib>Marko, Natalia</creatorcontrib><creatorcontrib>Grela, Wiktor</creatorcontrib><creatorcontrib>Głogowska, Paulina</creatorcontrib><creatorcontrib>Marciniuk, Dominika</creatorcontrib><creatorcontrib>Górska, Aleksandra</creatorcontrib><creatorcontrib>Gniaź, Natalia</creatorcontrib><collection>CrossRef</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Journal of education, health and sport</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tulej, Dawid</au><au>Furtak, Daria</au><au>Dziedzic, Alicja</au><au>Niewiadomska, Jagoda</au><au>Marko, Natalia</au><au>Grela, Wiktor</au><au>Głogowska, Paulina</au><au>Marciniuk, Dominika</au><au>Górska, Aleksandra</au><au>Gniaź, Natalia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cardiac Syndrome X: Advances in Treatment for Chest Pain without Artery Stenosis</atitle><jtitle>Journal of education, health and sport</jtitle><date>2024-12-21</date><risdate>2024</risdate><volume>76</volume><spage>56434</spage><pages>56434-</pages><issn>2391-8306</issn><eissn>2391-8306</eissn><abstract>The number of patients diagnosed with Cardiac Syndrome X continues to increase. This condition is marked by anginal pain despite the absence of abnormal findings on coronary angiography or coronary spasm. It is considered a form of ischemic heart disease, with its incidence being most common among women in the perimenopausal and postmenopausal stages. The aim of this article is to review therapeutic options for Cardiac Syndrome X. The most effective treatments commonly used include calcium channel blockers and beta-blockers, including newer generation options that promote vasodilation in the endothelium. Angiotensin-converting enzyme (ACE) inhibitors are also frequently used to enhance therapeutic outcomes. Other medications used were nitrates, statins, ranolazine, imipramine, nicorandil, aminophylline, cilostazol, sildenafil, fasudil. Emerging theories suggest altered pain perception, potentially involving heightened neural sensitivity, may significantly contribute to the symptoms in CSX. Additionally, studies indicate that vitamin D supplementation, often beneficial for cardiovascular health, may alleviate symptoms in CSX. Non-pharmacological methods also have proven efficacy, such as Enhanced External Counterpulsation, spinal cord stimulation and transcutaneous electrical nerve stimulation. Lifestyle changes and (CBT) also play a crucial role in the comprehensive management of Cardiac Syndrome X (CSX), targeting factors that pharmacological treatments alone may not address.</abstract><pub>Kazimierz Wielki University</pub><doi>10.12775/JEHS.2024.76.56434</doi><orcidid>https://orcid.org/0009-0003-2219-984X</orcidid><orcidid>https://orcid.org/0009-0008-3329-9770</orcidid><orcidid>https://orcid.org/0000-0003-0768-9800</orcidid><orcidid>https://orcid.org/0009-0000-0710-8485</orcidid><orcidid>https://orcid.org/0009-0004-0141-2821</orcidid><orcidid>https://orcid.org/0009-0002-3003-4466</orcidid><orcidid>https://orcid.org/0000-0002-5711-3423</orcidid><orcidid>https://orcid.org/0009-0004-7815-4592</orcidid><orcidid>https://orcid.org/0009-0001-0460-4106</orcidid><orcidid>https://orcid.org/0009-0000-5801-5756</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2391-8306
ispartof Journal of education, health and sport, 2024-12, Vol.76, p.56434
issn 2391-8306
2391-8306
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_040413007c4440888e8922302826e3e1
source DOAJ Directory of Open Access Journals
subjects cardiac syndrome X
ischemic heart disease
microvascular angina
pharmacological therapy
title Cardiac Syndrome X: Advances in Treatment for Chest Pain without Artery Stenosis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T15%3A38%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-doaj_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cardiac%20Syndrome%20X:%20Advances%20in%20Treatment%20for%20Chest%20Pain%20without%20Artery%20Stenosis&rft.jtitle=Journal%20of%20education,%20health%20and%20sport&rft.au=Tulej,%20Dawid&rft.date=2024-12-21&rft.volume=76&rft.spage=56434&rft.pages=56434-&rft.issn=2391-8306&rft.eissn=2391-8306&rft_id=info:doi/10.12775/JEHS.2024.76.56434&rft_dat=%3Cdoaj_cross%3Eoai_doaj_org_article_040413007c4440888e8922302826e3e1%3C/doaj_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1101-dad73975681c69e82201696e5b8e2d1401b5fdb5d92128de9bfc199c45786df13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true